Mapping neurosensory disorders and pain in patients treated for oral cavity and oropharynx cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate and map neurosensory disorders such as hypoesthesia and paresthesia in patients who have undergone treatment for cancers of the oral cavity and oropharynx. It involves a detailed assessment during routine follow-up consultations with maxillo-facial surgeons, where patient data, treatment history, and symptoms of peripheral neuropathy are collected. The study also includes diagnostic tests for neuropathic pain and quality of life assessments using standardized questionnaires.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient treated for an oral cavity and oropharynx tumor from at least one year and maximum five years.
* Women or men upper 18 years old)
* Patient with full consent, aware and signed
* Patient cover by the French social security system

Exclusion Criteria:

* Patient with mental disorder, psychologic, with a defect of comprehension to agree fully the protocol
* Pregnant women or nursing
* Patients who can't comply with the protocol
* Participation refusal
* Inable full age patient or under judicial protection

Where it's running

• CHU de Clermont-Ferrand
  Clermont-Ferrand, France Recruiting

Study contacts

• Principal investigator: Nathalie PHAM DANG — University Hospital, Clermont-Ferrand
• Study coordinator: Lise LACLAUTRE
• Email: promo_interne_drci@chu-clermontferrand.fr
• Phone: +33473754963

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prehabilitation program for patients with head and neck cancer

  This study is testing a prehabilitation program that includes exercise and nutrition support for people with head and neck cancer to see if it helps them feel better before surgery.

  Recruiting at 2 sites University of California, Davis · Sacramento, California and 1 other locations · NCT06722508

• Tinnitus and Hearing Loss in Head and Neck Cancer Treated with Radiotherapy or Chemoradiotherapy

  This study tests whether tinnitus that starts during treatment is linked to later hearing loss in adults with locally advanced head and neck cancer treated with radiotherapy alone or with chemotherapy.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT05946577

• Combining chemotherapy and immunotherapy for head and neck cancer treatment

  This study is testing if combining chemotherapy with immunotherapy drugs can help people with head and neck cancer before surgery and possibly reduce the need for radiation therapy afterward.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT04722523

• Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work

  This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.

  Recruiting at 2 sites Karolinska Institutet · Luleå, Norrbotten County and 2 other locations · NCT07924774

• One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital

  A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.

  Recruiting Ottawa Hospital Research Institute · Ottawa, Ontario · NCT07919626

• Meaning-Based Psychotherapy for Adults with Chronic Pain

  This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.

  Recruiting Hospital Clinico Universitario San Cecilio · Granada, Granada · NCT07915440

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.